OLIVIA WROBEL: Open Payments
NPI 1336709898 · LAKEWOOD RANCH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,104 in 41 payments from 11 companies in 2025. Trend: 2023 $1,049 · 2024 $1,643 · 2025 $1,104
Food & beverage: $1,010Education: $95
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 12 | $368 |
| ABBVIE INC. | 7 | $232 |
| Lilly USA, LLC | 4 | $115 |
| Galderma Laboratories, L.P. | 5 | $100 |
| PFIZER INC. | 3 | $86 |
| Janssen Biotech, Inc. | 3 | $55 |
| Novartis Pharmaceuticals Corporation | 2 | $53 |
| LEO Pharma Inc. | 1 | $30 |
| MAYNE PHARMA COMMERCIAL LLC | 2 | $27 |
| GENZYME CORPORATION | 1 | $19 |
Products named: DUPIXENT, SKYRIZI, CIBINQO, NEMLUVIO, EBGLYSS, TREMFYA, TALTZ, RINVOQ.
Industry payments across FL — which companies pay providers there.
